Company · CIK 1888012
HilleVax, Inc.
| CIK | 1888012 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2022-06-08 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-271892 | 2023-05-12 | 2025-09-22 | 5 | |
| 333-278110 | 2024-03-20 | 2025-09-22 | 3 | |
| 333-264159 | 2022-04-06 | 2022-04-29 | 5 |
Filings
14| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-09-22 | EFFECTDeclared effective | 333-278110 | 9999999995-25-003035 |
| 2025-09-22 | EFFECTDeclared effective | 333-271892 | 9999999995-25-003032 |
| 2024-05-09 | EFFECTDeclared effective | 333-278110 | 9999999995-24-001453 |
| 2024-03-20 | S-3Shelf registered | 333-278110 | 0001193125-24-072800 |
| 2023-09-20 | 424B5Shelf takedown | 333-271892 | 0001193125-23-238550 |
| 2023-09-19 | 424B5Shelf takedown | 333-271892 | 0001193125-23-237646 |
| 2023-05-19 | EFFECTDeclared effective | 333-271892 | 9999999995-23-001485 |
| 2023-05-12 | S-3Shelf registered | 333-271892 | 0001193125-23-143590 |
| 2022-04-29 | 424B4Final prospectus | 333-264159 | 0001193125-22-133531 |
| 2022-04-28 | EFFECTDeclared effective | 333-264159 | 9999999995-22-001141 |
| 2022-04-25 | S-1/AAmendment | 333-264159 | 0001193125-22-116250 |
| 2022-04-18 | S-1/AAmendment | 333-264159 | 0001193125-22-107271 |
| 2022-04-06 | S-1Registration filed | 333-264159 | 0001193125-22-097505 |
| 2021-10-19 | DRSDraft made public | 377-05605 | 0000950123-21-013303 |